Romano Brothers AND Company purchased a new stake in Healthpeak Properties, Inc. (NYSE:DOC – Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 65,054 shares of the real estate investment trust’s stock, valued at approximately $1,488,000.
A number of other hedge funds have also recently bought and sold shares of DOC. Rise Advisors LLC acquired a new position in shares of Healthpeak Properties in the 3rd quarter valued at approximately $29,000. Riverview Trust Co acquired a new stake in Healthpeak Properties in the third quarter valued at $35,000. UMB Bank n.a. bought a new position in Healthpeak Properties during the 3rd quarter valued at $40,000. Mather Group LLC. bought a new position in Healthpeak Properties during the 3rd quarter valued at $60,000. Finally, Livforsakringsbolaget Skandia Omsesidigt acquired a new position in Healthpeak Properties during the 3rd quarter worth $67,000. Institutional investors and hedge funds own 93.57% of the company’s stock.
Healthpeak Properties Stock Up 3.1 %
Healthpeak Properties stock opened at $23.12 on Thursday. The firm has a market capitalization of $16.27 billion, a P/E ratio of 66.06, a P/E/G ratio of 2.27 and a beta of 1.14. The company has a 50-day simple moving average of $22.21 and a 200-day simple moving average of $20.62. Healthpeak Properties, Inc. has a one year low of $15.24 and a one year high of $23.15. The company has a debt-to-equity ratio of 0.91, a quick ratio of 0.70 and a current ratio of 0.70.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently issued reports on DOC shares. Wells Fargo & Company restated an “equal weight” rating and issued a $23.00 target price (up previously from $22.00) on shares of Healthpeak Properties in a research note on Tuesday, October 1st. StockNews.com downgraded Healthpeak Properties from a “hold” rating to a “sell” rating in a report on Saturday, October 19th. Citigroup lifted their target price on Healthpeak Properties from $20.00 to $22.00 and gave the stock a “neutral” rating in a research report on Thursday, August 22nd. Scotiabank upped their price target on Healthpeak Properties from $23.00 to $24.00 and gave the company a “sector outperform” rating in a research report on Monday, September 9th. Finally, Deutsche Bank Aktiengesellschaft raised shares of Healthpeak Properties from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $20.00 to $28.00 in a report on Monday. One research analyst has rated the stock with a sell rating, five have issued a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $22.62.
Check Out Our Latest Stock Report on DOC
Healthpeak Properties Company Profile
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Recommended Stories
- Five stocks we like better than Healthpeak Properties
- Investing in Commodities: What Are They? How to Invest in Them
- Monster and Celsius Energized: Which Stock Offers More Upside?
- Insider Trades May Not Tell You What You Think
- Sherwin-Williams Plunges Into Buying Opportunity: Time to Buy?
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Wolverine World Wide Breaks Out – Will the 92% Rally Continue?
Want to see what other hedge funds are holding DOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthpeak Properties, Inc. (NYSE:DOC – Free Report).
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.